CJC 1295 (without DAC) 5mg + IPA 5mg

Product Specifications

Product Name: CJC-1295 (without DAC) + Ipamorelin (IPA)
Total Quantity: 10mg
Composition:
• CJC-1295 (without DAC) – 5mg
• Ipamorelin (IPA) – 5mg
Form: Lyophilised powder
Packaging: Sealed vial
Intended Use: Research purposes only

Research Context

CJC-1295 (without DAC) is a synthetic peptide analogue of growth hormone-releasing hormone (GHRH). In scientific literature, it is studied in in-vitro and experimental research models for its interaction with pituitary receptor signalling and peptide-receptor binding dynamics.

Research interest centres on molecular signalling pathways, peptide stability, and endocrine communication mechanisms under controlled laboratory conditions.

No claims are made regarding clinical outcomes or effects in humans or animals.

CJC-1295 (without DAC) combined with Ipamorelin (IPA) is a laboratory-grade research peptide blend supplied exclusively for scientific and analytical research purposes. This formulation consists of two synthetic peptides provided together in lyophilised powder form and manufactured under controlled conditions to ensure consistency and suitability for research environments.

This product is supplied strictly as a research compound. No claims are made regarding biological activity, outcomes, or suitability for any use outside of laboratory investigation.

Not intended for human or animal consumption.